The global Biosimilar Testing and Development Services market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
By Types:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
By Applications:
PK assay
Tiered Immunogenicity testing
NAb assays
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Biosimilar Testing and Development Services Market Size Analysis from 2023 to 2028
1.5.1 Global Biosimilar Testing and Development Services Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Biosimilar Testing and Development Services Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Biosimilar Testing and Development Services Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Biosimilar Testing and Development Services Industry Impact
Chapter 2 Global Biosimilar Testing and Development Services Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimilar Testing and Development Services (Volume and Value) by Type
2.1.1 Global Biosimilar Testing and Development Services Consumption and Market Share by Type (2017-2022)
2.1.2 Global Biosimilar Testing and Development Services Revenue and Market Share by Type (2017-2022)
2.2 Global Biosimilar Testing and Development Services (Volume and Value) by Application
2.2.1 Global Biosimilar Testing and Development Services Consumption and Market Share by Application (2017-2022)
2.2.2 Global Biosimilar Testing and Development Services Revenue and Market Share by Application (2017-2022)
2.3 Global Biosimilar Testing and Development Services (Volume and Value) by Regions
2.3.1 Global Biosimilar Testing and Development Services Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Biosimilar Testing and Development Services Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biosimilar Testing and Development Services Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Biosimilar Testing and Development Services Consumption by Regions (2017-2022)
4.2 North America Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
4.10 South America Biosimilar Testing and Development Services Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Biosimilar Testing and Development Services Market Analysis
5.1 North America Biosimilar Testing and Development Services Consumption and Value Analysis
5.1.1 North America Biosimilar Testing and Development Services Market Under COVID-19
5.2 North America Biosimilar Testing and Development Services Consumption Volume by Types
5.3 North America Biosimilar Testing and Development Services Consumption Structure by Application
5.4 North America Biosimilar Testing and Development Services Consumption by Top Countries
5.4.1 United States Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
5.4.2 Canada Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
5.4.3 Mexico Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 6 East Asia Biosimilar Testing and Development Services Market Analysis
6.1 East Asia Biosimilar Testing and Development Services Consumption and Value Analysis
6.1.1 East Asia Biosimilar Testing and Development Services Market Under COVID-19
6.2 East Asia Biosimilar Testing and Development Services Consumption Volume by Types
6.3 East Asia Biosimilar Testing and Development Services Consumption Structure by Application
6.4 East Asia Biosimilar Testing and Development Services Consumption by Top Countries
6.4.1 China Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
6.4.2 Japan Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
6.4.3 South Korea Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 7 Europe Biosimilar Testing and Development Services Market Analysis
7.1 Europe Biosimilar Testing and Development Services Consumption and Value Analysis
7.1.1 Europe Biosimilar Testing and Development Services Market Under COVID-19
7.2 Europe Biosimilar Testing and Development Services Consumption Volume by Types
7.3 Europe Biosimilar Testing and Development Services Consumption Structure by Application
7.4 Europe Biosimilar Testing and Development Services Consumption by Top Countries
7.4.1 Germany Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.2 UK Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.3 France Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.4 Italy Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.5 Russia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.6 Spain Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.7 Netherlands Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.8 Switzerland Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
7.4.9 Poland Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 8 South Asia Biosimilar Testing and Development Services Market Analysis
8.1 South Asia Biosimilar Testing and Development Services Consumption and Value Analysis
8.1.1 South Asia Biosimilar Testing and Development Services Market Under COVID-19
8.2 South Asia Biosimilar Testing and Development Services Consumption Volume by Types
8.3 South Asia Biosimilar Testing and Development Services Consumption Structure by Application
8.4 South Asia Biosimilar Testing and Development Services Consumption by Top Countries
8.4.1 India Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
8.4.2 Pakistan Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Biosimilar Testing and Development Services Market Analysis
9.1 Southeast Asia Biosimilar Testing and Development Services Consumption and Value Analysis
9.1.1 Southeast Asia Biosimilar Testing and Development Services Market Under COVID-19
9.2 Southeast Asia Biosimilar Testing and Development Services Consumption Volume by Types
9.3 Southeast Asia Biosimilar Testing and Development Services Consumption Structure by Application
9.4 Southeast Asia Biosimilar Testing and Development Services Consumption by Top Countries
9.4.1 Indonesia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.2 Thailand Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.3 Singapore Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.4 Malaysia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.5 Philippines Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.6 Vietnam Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
9.4.7 Myanmar Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 10 Middle East Biosimilar Testing and Development Services Market Analysis
10.1 Middle East Biosimilar Testing and Development Services Consumption and Value Analysis
10.1.1 Middle East Biosimilar Testing and Development Services Market Under COVID-19
10.2 Middle East Biosimilar Testing and Development Services Consumption Volume by Types
10.3 Middle East Biosimilar Testing and Development Services Consumption Structure by Application
10.4 Middle East Biosimilar Testing and Development Services Consumption by Top Countries
10.4.1 Turkey Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.3 Iran Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.5 Israel Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.6 Iraq Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.7 Qatar Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.8 Kuwait Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
10.4.9 Oman Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 11 Africa Biosimilar Testing and Development Services Market Analysis
11.1 Africa Biosimilar Testing and Development Services Consumption and Value Analysis
11.1.1 Africa Biosimilar Testing and Development Services Market Under COVID-19
11.2 Africa Biosimilar Testing and Development Services Consumption Volume by Types
11.3 Africa Biosimilar Testing and Development Services Consumption Structure by Application
11.4 Africa Biosimilar Testing and Development Services Consumption by Top Countries
11.4.1 Nigeria Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
11.4.2 South Africa Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
11.4.3 Egypt Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
11.4.4 Algeria Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
11.4.5 Morocco Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 12 Oceania Biosimilar Testing and Development Services Market Analysis
12.1 Oceania Biosimilar Testing and Development Services Consumption and Value Analysis
12.2 Oceania Biosimilar Testing and Development Services Consumption Volume by Types
12.3 Oceania Biosimilar Testing and Development Services Consumption Structure by Application
12.4 Oceania Biosimilar Testing and Development Services Consumption by Top Countries
12.4.1 Australia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
12.4.2 New Zealand Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 13 South America Biosimilar Testing and Development Services Market Analysis
13.1 South America Biosimilar Testing and Development Services Consumption and Value Analysis
13.1.1 South America Biosimilar Testing and Development Services Market Under COVID-19
13.2 South America Biosimilar Testing and Development Services Consumption Volume by Types
13.3 South America Biosimilar Testing and Development Services Consumption Structure by Application
13.4 South America Biosimilar Testing and Development Services Consumption Volume by Major Countries
13.4.1 Brazil Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.2 Argentina Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.3 Columbia Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.4 Chile Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.5 Venezuela Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.6 Peru Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
13.4.8 Ecuador Biosimilar Testing and Development Services Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Biosimilar Testing and Development Services Business
14.1 Eurofins Scientific
14.1.1 Eurofins Scientific Company Profile
14.1.2 Eurofins Scientific Biosimilar Testing and Development Services Product Specification
14.1.3 Eurofins Scientific Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 SGS
14.2.1 SGS Company Profile
14.2.2 SGS Biosimilar Testing and Development Services Product Specification
14.2.3 SGS Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Charles River Laboratories
14.3.1 Charles River Laboratories Company Profile
14.3.2 Charles River Laboratories Biosimilar Testing and Development Services Product Specification
14.3.3 Charles River Laboratories Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Pharmaceutical Product Development
14.4.1 Pharmaceutical Product Development Company Profile
14.4.2 Pharmaceutical Product Development Biosimilar Testing and Development Services Product Specification
14.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Exova
14.5.1 Exova Company Profile
14.5.2 Exova Biosimilar Testing and Development Services Product Specification
14.5.3 Exova Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Source BioScience
14.6.1 Source BioScience Company Profile
14.6.2 Source BioScience Biosimilar Testing and Development Services Product Specification
14.6.3 Source BioScience Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Intertek Group
14.7.1 Intertek Group Company Profile
14.7.2 Intertek Group Biosimilar Testing and Development Services Product Specification
14.7.3 Intertek Group Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Medistri
14.8.1 Medistri Company Profile
14.8.2 Medistri Biosimilar Testing and Development Services Product Specification
14.8.3 Medistri Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Pace Analytical Services
14.9.1 Pace Analytical Services Company Profile
14.9.2 Pace Analytical Services Biosimilar Testing and Development Services Product Specification
14.9.3 Pace Analytical Services Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Sigma-Aldrich
14.10.1 Sigma-Aldrich Company Profile
14.10.2 Sigma-Aldrich Biosimilar Testing and Development Services Product Specification
14.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Biosimilar Testing and Development Services Market Forecast (2023-2028)
15.1 Global Biosimilar Testing and Development Services Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Biosimilar Testing and Development Services Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Biosimilar Testing and Development Services Value and Growth Rate Forecast (2023-2028)
15.2 Global Biosimilar Testing and Development Services Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Biosimilar Testing and Development Services Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Biosimilar Testing and Development Services Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Biosimilar Testing and Development Services Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Biosimilar Testing and Development Services Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Biosimilar Testing and Development Services Consumption Forecast by Type (2023-2028)
15.3.2 Global Biosimilar Testing and Development Services Revenue Forecast by Type (2023-2028)
15.3.3 Global Biosimilar Testing and Development Services Price Forecast by Type (2023-2028)
15.4 Global Biosimilar Testing and Development Services Consumption Volume Forecast by Application (2023-2028)
15.5 Biosimilar Testing and Development Services Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 115 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 129 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 123 |
Request Sample 
Request Discount 
Inquire Before Buy
